STAT+: Genentech is soliciting research that can be used to blunt pharma reforms in Washington

Genentech is offering up to $125,000 in research grants to academics to generate papers on topics aligned with pharmaceutical industry talking points against drug pricing reforms, including studies on innovation impacts and R&D risks. The company is seeking 'rigorous, independent' research that could be used to influence Capitol Hill policy discussions on healthcare affordability.